HCPCS code J9038 — Inj axatilimab-csfr 0.1 mg. Status: Active. Effective Jul 1, 2025. Source: CMS HCPCS Level II.

J9038

Active

Inj axatilimab-csfr 0.1 mg

Injection, axatilimab-csfr, 0.1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0839

MUE — Medically Unlikely Edits

Maximum units of J9038 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 360
Outpatient Hospital 360
Practitioner Services 360

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
50881-0012-10 Niktimvo
50881-0023-11 Niktimvo
50881-0034-12 Niktimvo

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q3
    Inj axatilimab-csfr 0.1 mg